You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BSA

Showing 1 - 25 of 1,396
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gynecologic Malignancies Trial in Cleveland (Paclitaxel, Carboplatin)

Terminated
Has Results
  • Gynecologic Malignancies
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jun 29, 2022

Cognitive Dysfunction, Mild Cognitive Impairment Trial in Badalona (Virtual Reality Cognitive Stimulation Program)

Recruiting
  • Cognitive Dysfunction
  • Mild Cognitive Impairment
  • Virtual Reality Cognitive Stimulation Program
  • Badalona, Barcelona, Spain
    Centro Socio Sanitario El Carmen
Dec 1, 2023

Suicide, Risk Reduction Trial in Fort Campbell North (Building Stronger Allies, Health Education Training)

Completed
  • Suicide
  • Risk Reduction
  • Building Stronger Allies
  • Health Education Training
  • Fort Campbell North, Kentucky
    101st Airborne Division (Air Assault) Combat Aviation Brigade
Apr 18, 2022

Moderate Plaque Psoriasis Trial in Miami, Houston, San Antonio (Guselkumab, Placebo)

Recruiting
  • Moderate Plaque Psoriasis
  • Miami, Florida
  • +3 more
Sep 9, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial (Biospecimen Collection, Vincristine)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Birmingham, Alabama
  • +20 more
Jan 23, 2023

Psoriasis Trial in United States (Ruxolitinib)

Completed
Has Results
  • Psoriasis
  • Fridley, Minnesota
  • +3 more
Feb 4, 2022

Tailored Implementation: Online ItFits-toolkit, Implementation as Usual Trial in Worldwide (ItFits-toolkit, Implementation as

Completed
  • Tailored Implementation: Online ItFits-toolkit
  • Implementation as Usual
  • ItFits-toolkit
  • Implementation as Usual
  • Tirana, Albania
  • +11 more
Mar 10, 2021

Granuloma Annulare Trial in New Haven (Abrocitinib 200 mg)

Not yet recruiting
  • Granuloma Annulare
  • Abrocitinib 200 mg
  • New Haven, Connecticut
    Yale University
Dec 19, 2022

Atopic Dermatitis Trial in New York, Philadelphia (1.1% w/w AMTX-100 CF, 0.33% w/w AMTX-100 CF, 0.11% w/w AMTX-100 CF)

Active, not recruiting
  • Atopic Dermatitis
  • 1.1% w/w AMTX-100 CF
  • +3 more
  • New York, New York
  • +1 more
Sep 27, 2022

Burns Trial in Riyadh (Enoxaparin 40 mg q24 hours, Enoxaparin 30 mg q12 hours, Unfractionated heparin 5000 U q8 hours)

Completed
  • Burns
  • Enoxaparin 40 mg q24 hours
  • +2 more
  • Riyadh, Saudi Arabia
    King Abdulaziz Medical City
Dec 17, 2022

Nonsegmental Vitiligo With Genital Involvement Trial (Ruxolitinib Cream)

Not yet recruiting
  • Nonsegmental Vitiligo With Genital Involvement
  • Ruxolitinib Cream
  • (no location specified)
Feb 20, 2023

Vitiligo, JAK Inhibitor Trial in Canada, United States (Ruxolitinib 1.5% cream, NB-UVB phototherapy)

Recruiting
  • Vitiligo
  • JAK Inhibitor
  • Ruxolitinib 1.5% cream
  • NB-UVB phototherapy
  • Fountain Valley, California
  • +13 more
Jul 6, 2022

Non Small Cell Lung Cancer, Mesothelioma Trial in Netherlands (Pemetrexed)

Terminated
  • Non Small Cell Lung Cancer
  • Mesothelioma
  • 's-Hertogenbosch, Netherlands
  • +4 more
May 9, 2022

Colitis, Ulcerative Trial in Worldwide (Ustekinumab Dose Based on BSA and Body Weight, Matching Placebo)

Recruiting
  • Colitis, Ulcerative
  • Ustekinumab Dose Based on BSA and Body Weight
  • Matching Placebo
  • Wilmington, Delaware
  • +68 more
Jan 31, 2023

Stage III Colon Cancer Trial in France (Oxaliplatin, Oxaliplatin LBM)

Active, not recruiting
  • Stage III Colon Cancer
  • Marseille, Bouches Du Rhône, France
  • +10 more
Aug 2, 2022

Atopic Dermatitis Trial in Beer Sheva (Medihoney Derma Cream, Hydrocortisone 1% cream)

Completed
  • Atopic Dermatitis
  • Medihoney Derma Cream
  • Hydrocortisone 1% cream
  • Beer Sheva, Israel
    Soroka University Medical Center
Mar 2, 2022

Atopic Dermatitis Trial in China, Japan, Korea, Republic of (Crisaborole Ointment, Crisaborole Placebo Vehicle)

Completed
Has Results
  • Atopic Dermatitis
  • Crisaborole Ointment
  • Crisaborole Placebo Vehicle
  • Beijing, Beijing, China
  • +38 more
May 12, 2022

Non-segmental Vitiligo Trial in Worldwide (Ruxolitinib cream, Vehicle)

Completed
  • Non-segmental Vitiligo
  • Hoover, Alabama
  • +56 more
Mar 8, 2022

Locally Advanced Esophageal and Gastric Cancers (EGC) Trial in Durham (Pembrolizumab)

Active, not recruiting
  • Locally Advanced Esophageal and Gastric Cancers (EGC)
  • Durham, North Carolina
    Duke Cancer Center
Dec 7, 2022

Non-segmental Vitiligo Trial in Worldwide (Ruxolitinib cream, Vehicle)

Completed
  • Non-segmental Vitiligo
  • Gilbert, Arizona
  • +75 more
Mar 8, 2022

PASI Scoring Using Digital-Based Images

Not yet recruiting
  • Plaque Psoriasis
  • In-Person and Remote Disease Assessment
  • (no location specified)
Apr 18, 2023

Progression-free Survival Trial (Sovalteinib Solutumab Tegeo)

Not yet recruiting
  • Progression-free Survival
  • Sovalteinib Solutumab Tegeo
  • (no location specified)
Jul 24, 2023

Psoriasis Trial in Worldwide (HRO350, Placebo)

Recruiting
  • Psoriasis
  • Helsinki, Finland
  • +48 more
Nov 8, 2023

NSCLC, Brain Metastases Trial in Guangzhou (Anlotinib)

Recruiting
  • Non-small Cell Lung Cancer
  • Brain Metastases
  • Guangzhou, China
    Sun Yat-Sen University Cancer Center
Jul 20, 2021

Atopic Dermatitis Trial in Kotara (BioLexa- Cohort 1, BioLexa- Cohort 2, Placebo)

Completed
  • Atopic Dermatitis
  • BioLexa- Cohort 1
  • +3 more
  • Kotara, New South Wales, Australia
    Novatrials
Nov 14, 2022